Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

3.54
+0.14004.12%
Volume:476.82K
Turnover:1.65M
Market Cap:153.27M
PE:-4.57
High:3.55
Open:3.36
Low:3.36
Close:3.40
52wk High:5.06
52wk Low:1.62
Shares:43.30M
Float Shares:37.42M
Volume Ratio:1.29
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7754
EPS(LYR):-1.3374
ROE:-682.61%
ROA:-63.99%
PB:-901.57
PE(LYR):-2.65

Loading ...

NRX Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

NRX Pharmaceuticals Q1 EPS $(0.04) Up From $(0.34) YoY, Sales $1.068M

Benzinga Earnings
·
May 16

NRx Pharma Q1 FY26 net loss narrows to $1.43 million; revenue turns to $1.07 million

Reuters
·
May 16

NRX Pharmaceuticals Inc expected to post earnings of 29 cents a share - Earnings Preview

Reuters
·
May 15

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
·
May 15

NRx Pharmaceuticals to report Q1 2026 results, host conference call

Reuters
·
May 14

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) to Report First Quarter 2026 Financial Results and Provide Corporate Update

THOMSON REUTERS
·
May 14

NRX Pharmaceuticals Inc expected to post earnings of 29 cents a share - Earnings Preview

Reuters
·
May 11

NRx Pharmaceuticals wins FDA clearance to start NRX-101 depression, suicidality trial

Reuters
·
May 07

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 06

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine

GlobeNewswire
·
May 05

NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Apr 27

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 23

NRX Pharmaceuticals Inc - Receives Positive FDA Discipline Review Letter Requesting Only Minor Administrative Changes

THOMSON REUTERS
·
Apr 22

NRX Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program

THOMSON REUTERS
·
Apr 22

NRX Pharmaceuticals Inc - FDA Office of Generic Drugs Voices Support for NRX Anda Approval in Current Review Cycle

THOMSON REUTERS
·
Apr 22

NRX Pharmaceuticals Inc - in the Process of of Submitting Nda to Align Ketamine Labeling With Depression and Suicidality Treatment

THOMSON REUTERS
·
Apr 22

White House shift on psychedelics positive for NRx, says D. Boral

TIPRANKS
·
Apr 20

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 20

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

GlobeNewswire
·
Apr 20